| Adult Nurse Practitioner in Primary and Palliative Care (ANP)
Sample Plan of Study | Post-BSN (part-time study options are available)
Applies to all students entering Fall semester | |
| NURSM | 600 | Applied Physiology | 3 sh | (2,1,0) | | NURSM | 624 | Advanced Health Assessment¹ | 4 sh | (3,0,1) | | NURSM | 650 | Foundations and Issues in Palliative Care | 3 sh | (3,0,0) | |
| NURSM | 639 | Advanced Practice in Health Promotion and Risk Reduction¹ | 4 sh | (0,1,3) | | NURSM | 751 | Foundations of Advanced Practice Nursing | 3 sh | (3,0,0) | | NURSM | 781 | Pharmacotherapeutics for Advanced Practice Nurses² | 3 sh | (3,0,0) | | NURSM | 804 | Statistics for Health Care Research | 3 sh | (3,0,0) | |
| NURSM | 608 | Advanced Practice in Episodic and Chronic Conditions: Adult¹ | 4 sh | (0,1,3) | | NURSM | 768 | Research and Evidence-Based Nursing | 3 sh | (3,0,0) | | NURSM | 803 | Spirituality and Palliative Care | 2 sh | (0,2,0) | |
| NURSM | 647 | Palliative Care I: Management of Physical and Environmental Domains | 1 sh | (0,1,0) | | NURSM | 648 | Advanced Practice in Palliative Care I: Management of Physical and Environmental Domains¹ | 3 sh | (0,0,3) | | NURSM | 651 | Palliative Care II: Management of Psychosocial Domains | 1 sh | (0,1,0) | | NURSM | 652 | Advanced Practice in Palliative Care II: Management of Pyschosocial Domains¹ | 3 sh | (0,0,3) | | NURSM | 769 | Health Care Finance | 2 sh | (2,0,0) | |
| NURSM | 764 | Advanced Practice Nursing: Role Residency¹ | 6 sh | (0,1,5) | | NURSM | 649 | Interdisciplinary Seminars in Palliative Care | 1 sh | (0,1,0) | | NURSM | 777 | Advanced Practice Role and Scope | 1 sh | (1,0,0) | | NURSM | 802 | Health Policy, Research, and Issues for Advanced Practice Nurses | 2 sh | (2,0,0) | | NURSM | 805 | Controlled Sustance Prescribing for the APRN | 1 sh | (1,0,0) | | Thesis or Scholarly Project | (0-6 sh) | | | Minimum MSN course work | 51 sh |
|
¹Clinical component
²May be challenged with prescriptive authority
Semester hour breakdown: 1:1 (Didactic), 2:1 (Seminar), 3:1 (Clinical/lab) |
|
|
